COST-EFFECTIVENESS OF VARENICLINE VERSUS EXISTING SMOKING CESSATION STRATEGIES IN BRAZIL FROM THE PUBLIC PERSPECTIVE, USING THE BENESCO MODEL

被引：0
|
作者：
Fujii, R. [1 ]
Correia, E. A. [1 ]
Mould, J. F. [2 ]
机构：
[1] Pfizer Pharmaceut Inc, Sao Paulo, Brazil
[2] Pfizer Inc, New York, NY USA
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 07期
关键词：
D O I：
10.1016/j.jval.2011.08.1388
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A487 / A487
页数：1
相关论文
共 50 条
  • [41] Cost-effectiveness analysis of treatment with varenicline for nicotine dependence compared with smoking cessation without pharmacotherapy in the real world
    Fujita, Takako
    Babazono, Akira
    Jiang, Peng
    Jamal, Aziz
    Li, Yunfei
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 (02) : 187 - 195
  • [42] COST-EFFECTIVENESS ANALYSIS OF SMOKING CESSATION INTERVENTIONS IN JAPAN USING THE DISCRETE EVENT SIMULATION MODEL
    Igarashi, A.
    Goto, R.
    Yoshikawa, R.
    Suwa, K.
    Ward, A. J.
    Moller, J.
    VALUE IN HEALTH, 2015, 18 (03) : A174 - A174
  • [43] Cost-effectiveness of alternative smoking cessation scenarios in Spain: results from the EQUIPTMOD
    Trapero-Bertran, Marta
    Munoz, Celia
    Coyle, Kathryn
    Coyle, Doug
    Lester-George, Adam
    Leidl, Reiner
    Nemeth, Bertalan
    Cheung, Kei-Long
    Pokhrel, Subhash
    Lopez-Nicolas, Angel
    ADDICTION, 2018, 113 : 65 - 75
  • [44] Lessons from Cost-Effectiveness Analysis of Smoking Cessation Programs for Cancer Patients
    Hoch, Jeffrey S.
    Barr, Heather K.
    Guggenbickler, Andrea M.
    Dewa, Carolyn S.
    CURRENT ONCOLOGY, 2022, 29 (10) : 6982 - 6991
  • [45] Cost-effectiveness analysis of pharmaceutical care for hypertensive patients from the perspective of the public health system in Brazil
    Cazarim, Maurilio de Souza
    Leira Pereira, Leonardo Regis
    PLOS ONE, 2018, 13 (03):
  • [46] Cost-effectiveness of increasing the reach of smoking cessation interventions in Germany: results from the EQUIPTMOD
    Huber, Manuel B.
    Praeger, Maximilian
    Coyle, Kathryn
    Coyle, Doug
    Lester-George, Adam
    Trapero-Bertran, Marta
    Nemeth, Bertalan
    Cheung, Kei Long
    Stark, Renee
    Vogl, Matthias
    Pokhrel, Subhash
    Leidl, Reiner
    ADDICTION, 2018, 113 : 52 - 64
  • [47] Cost-effectiveness of different combinations of bupropion SR dose and behavioral treatment for smoking cessation: A societal perspective
    Javitz, HS
    Swan, GE
    Zbikowski, SM
    Curry, SJ
    McAfee, TA
    Decker, DL
    Patterson, R
    Jack, LM
    AMERICAN JOURNAL OF MANAGED CARE, 2004, 10 (03): : 217 - 226
  • [48] Cost-effectiveness analysis for implementation of smoking cessation strategies at primary health care settings in Tamil Nadu
    Mahalingam, Vasantha
    Santhanakrishnan, Ramesh Kumar
    Malaisamy, Muniyandi
    Chelvanayagam, Karthick
    Mathiyazhagan, Kavi
    Bhaskar, Adhin
    Nagarajan, Karikalan
    Maria Selvam, Jerard
    Veeraiah, Surendran
    Rajsekar, Kavitha
    Tyagi, Kirti
    Chinnaiyan, Ponnuraja
    PLOS ONE, 2025, 20 (01):
  • [49] Towards optimum smoking cessation interventions during pregnancy: a household model to explore cost-effectiveness
    Avsar, Tuba Saygin
    Jackson, Louise
    Barton, Pelham
    Jones, Matthew
    McLeod, Hugh
    ADDICTION, 2022, 117 (10) : 2707 - 2719
  • [50] Cost-Effectiveness Analysis of Smoking Cessation Interventions in Japan Using a Discrete-Event Simulation
    Igarashi, Ataru
    Goto, Rei
    Suwa, Kiyomi
    Yoshikawa, Reiko
    Ward, Alexandra J.
    Moller, Joergen
    APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2016, 14 (01) : 77 - 87
12345